Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BA urges UK to take "leadership" in resumption of international travel

Sun, 14th Mar 2021 09:53

(Alliance News) - The UK should be a global leader in reopening international travel due to its "great progress" in tackling the coronavirus pandemic, according to the boss of British Airways.

Chief Executive Sean Doyle urged the government to "set an example" and "be ambitious" in developing systems which enable people to travel overseas.

This includes the use of digital technology to verify the vaccination and test status of passengers, he explained.

Doyle said the UK can be "very proud" of the creation of the Oxford/AstraZeneca vaccine and the relatively high number of people who have already received a Covid-19 jab compared with other countries.

"We're making great progress in Britain in dealing with the pandemic," he told reporters.

"It's fair to say that Britain has developed a really strong leadership position in coming out the other end of the pandemic.

"What we want to make sure is that we also take that leadership position into restoring travel and restoring the economy."

He added: "We can be ambitious, and we can pursue this opportunity in a way that others could follow."

British Airways, part of International Consolidated Airlines Group SA, is trialling the use of a "mobile travel health passport", produced by VeriFLY, to enable passengers travelling from London to the US to prove they meet US entry requirements before they board a flight.

Doyle, who replaced Alex Cruz as the carrier's boss in October 2020, warned that the UK will find it "very hard" to reopen for business and investment if travel remains heavily restricted.

It is "pretty obvious that governments and countries want to accept British travellers again", Doyle said, citing recent announcements from France, Spain, Portugal, Greece and Cyprus about easing border restrictions.

But "rapid action" and "global coordination" is required, according to Doyle.

"We do need to work across multiple governments and jurisdictions, and I think we have a great opportunity to drive that leadership position.

"For us, it's quite simple. I think people who've been vaccinated should be able to travel without restriction, and those who have not been vaccinated should be able to travel with a negative test result.

"It's worth reflecting on the fact that testing availability and testing solutions are in a far better place than they were a year ago, and they're much more affordable."

British Airways' owner IAG suffered a pre-tax loss of EUR7.8 billion in 2020 as demand for travel collapsed due to the virus crisis.

Doyle admitted it has been "a pretty brutal and tough 12 months".

But he said British Airways has seen a "surge" in bookings for flights from May 17, which is the earliest date that foreign leisure travel could be permitted for people living in England.

He added: "The summer holiday is something that people are holding out hope for."

The UK government's Global Travel Taskforce will provide a report to Prime Minister Boris Johnson on April 12 setting out recommendations for how and when overseas trips could resume.

By Neil Lancefield, PA Transport Correspondent

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.